PP
NTUS

Paloma Partners’s Natus Medical Inc NTUS Stock Holding History

Paloma Partners’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,105
Closed -$218K – 1899
2018
Q3 		$218K Buy
+6,105
New +$216K ﹤0.01% 1362
2018
Q1 		– Sell
-25,070
Closed -$957K – 2351
2017
Q4 		$957K Buy
+25,070
New +$1M 0.01% 1055
2017
Q3 		– Sell
-7,926
Closed -$296K – 2561
2017
Q2 		$296K Buy
+7,926
New +$286K ﹤0.01% 1802
2017
Q1 		– Sell
-21,685
Closed -$754K – 2323
2016
Q4 		$754K Buy
21,685
+6,848
+46% +$269K 0.01% 1319
2016
Q3 		$583K Buy
+14,837
New +$592K 0.01% 1333
2016
Q2 		– Sell
-6,421
Closed -$247K – 2394
2016
Q1 		$247K Sell
6,421
-4,881
-43% -$182K ﹤0.01% 1626
2015
Q4 		$543K Buy
+11,302
New +$523K 0.01% 993
2015
Q3 		– Sell
-11,000
Closed -$468K – 2032
2015
Q2 		$468K Buy
+11,000
New +$438K 0.01% 1124

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Paloma Partners's NTUS Position: Q4 2018 in Review

Paloma Partners sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 6,105 shares — an estimated $218K sold.

Paloma Partners first reported a position in NTUS in Q2 2015 and held it in 8 quarters. The position peaked at $957K in Q4 2017. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

  • Paloma Partners reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
  • Paloma Partners sold 6,105 Natus Medical Inc shares in Q4 2018, an estimated $218K.
  • Paloma Partners first reported a position in Natus Medical Inc in Q2 2015 and held it in 8 quarters.
  • Paloma Partners's Natus Medical Inc position peaked at $957K in Q4 2017.
  • 174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Paloma Partners's 13F filing for Q4 2018, filed 14 Feb 2019.